• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotec Pharmacon ASA

+ Add to Watchlist


15.0000 NOK 1.3000 9.49%

As of 12:00:02 ET on 11/07/2014.

Snapshot for Biotec Pharmacon ASA (BIOTEC)

Open: 15.0000 Day's Range: 15.0000 - 15.0000 Volume: 4
Previous Close: 13.7000 52wk Range: 10.8000 - 24.2000 1-Yr Rtn: -

Stock Chart for BIOTEC

No chart data available.
  • BIOTEC:SS 15.0000
  • 1D
  • 1M
  • 1Y
Interactive BIOTEC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIOTEC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -0.4300
Est. PEG Ratio -
Market Cap (M NOK) 652.63
Shares Outstanding (M) 43.51
30 Day Average Volume 1
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIOTEC

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for BIOTEC

Biotec Pharmacon ASA develops, manufactures and markets immune modulating compounds for the human and animal health sectors and marine enzymes used in molecular biology. The Company develops products to prevent or treat diseases caused by the failure, imbalance, and over-reaction of the immune system.

Svein W F LienChief Executive OfficerArvid VangenCFO/CAO
Rolf EngstadCSO
More Company Profile & Key Executives for BIOTEC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil